State’s DHS Moving to New Phase of Remdesivir Distribution
As directed by the U.S. Department of Health and Human Services (HHS), the State of Wisconsin is moving into a new phase of Remdesivir distribution as early as next week. Currently, the Wisconsin Department of Health Services (DHS) receives a weekly allocation from HHS and distributes that supply based on requests that hospitals submit. The supply is distributed to hospitals free-of-charge. Going forward the state will continue to allocate Remdesivir, but hospitals will be invoiced by the Remdesivir distributor, AmerisourceBergen. When indicating a desire to receive a Remdesivir distribution you are also agreeing to pay for the drug you receive.
This Fact Sheet
from HHS provides more detail, including the cost of Remdesivir; hospitals will pay no more than the wholesale acquisition cost (WAC) set by Gilead, which amounts to approximately $3,200 per treatment course.
For more information, contact email@example.com
, a special email account multiple DHS staff monitor.
This story originally appeared in the July 09, 2020 edition of WHA Newsletter